Cycloserine

This classification denotes an antitubercular agent with the molecular formula C3H6N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 95IK5KI84Z, chemically known as 3-isoxazolidinone, 4-amino-, (s)- but generally known as cycloserine, which bears US NIH Compound Identifier 401. European Medicines Agency schedules Cycloserine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06863MIG. The term CYCLOSERINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules cycloserine in its Anatomical Therapeutic Chemical (ATC) Classification. CYCLOSERINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cycloserine under HS 29419000 and SITC 54139. As of Q4 2014, CYCLOSERINE remains the US FDA Preferred Term for this commodity. Cycloserine bears US NLM identifiers UMLS ID C0010590 and NCI Concept Code C47466. SMILES: O1NC(=O)C(N)C1.